Medicine and Dentistry
Atrial Fibrillation
100%
New-Onset Atrial Fibrillation
75%
Hazard Ratio
54%
Prospective Cohort Study
50%
Apoplexy
50%
Disease
43%
Fatty Liver
25%
Gender and Sex
25%
Mental Performance
25%
Physical Activity
25%
middle age
25%
Lifespan
25%
Parkinson's Disease
25%
UK Biobank
12%
Proportional Hazards Model
11%
Menopause
8%
Steatosis
8%
Menstrual Cycle
8%
Menarche
8%
Arrhythmia
6%
Gray Matter
6%
Linear Regression Analysis
6%
Magnetic Resonance Imaging
6%
Hippocampus
6%
Electrocardiogram
5%
Prevalence
5%
Principal Component Analysis
5%
Multiple Chronic Conditions
5%
Odds Ratio
5%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
100%
New-Onset Atrial Fibrillation
50%
Genetic Risk
25%
Hearing Disorder
25%
Genetic Predisposition
25%
Prospective Cohort Study
25%
Cardiovascular Risk
25%
Ischemic Heart Disease
25%
Antihypertensive Drug
25%
Cardiovascular Disease
21%
Tinnitus
18%
Cerebrovascular Accident
18%
All Cause Mortality
18%
Hearing Impairment
12%
Cardiovascular Mortality
12%
Persistent Atrial Fibrillation
8%
Antihypertensive Agent
7%
Calcium Channel Blocker
7%
Beta Adrenergic Receptor Blocking Agent
7%
Alpha Adrenergic Receptor Blocking Agent
7%
Heart Arrhythmia
5%
Biochemistry, Genetics and Molecular Biology
Atrial Fibrillation
75%
Population
50%
Body Fat
25%
Lipid Storage
25%
Prospective Cohort Study
25%
Lifespan
25%
Arterial Stiffness
25%
Fat Mass
11%
All Cause Mortality
8%